Explore BRAIN Biotech AG’s FY-2022 Financial Performance with CFO Michael Schneiders as he delves into the company’s growth, challenges, and future prospects.
Â
Gain a comprehensive understanding of the group’s structure, including its subsidiaries Akibion Genomics and Brain Incubator, and their impact on the financial landscape.
Â
Uncover the financial highlights, such as revenue growth, adjusted EBITDA, and cash flow, while learning about the company’s regional revenue distribution and strategies for navigating general risk factors. Get a glimpse of BRAIN Biotech’s ambitious targets and share ownership structure as it strives to build a solid foundation for long-term success.
Â
As a leader in industrial biotechnology, BRAIN Biotech AG is dedicated to providing bio-based products and solutions for a more sustainable economy and is a proud participant in the United Nations Global Compact.
Reviews for BRAIN Biotech AG Financial Results FY 2022 | Exploring Growth, Challenges, and Future Prospects with CFO